Back to the search results

RoMed Klinikum Rosenheim

RoMed Klinikum Rosenheim
RoMed Klinikum Rosenheim

Ellmaierstraße 23
83022 Rosenheim

Phone: 08031-36502
Fax: +498031-365-4820
Mail: ed.dem-or@or.ofni

  • Number of beds: 622
  • Number of specialist departments: 17
  • Number of inpatient cases: 27.675
  • Number of partial inpatient cases: 1.483
  • Number of outpatient cases: 42.183
  • Hospital owners: RoMed Kliniken, Kliniken der Stadt und des Landkreises Rosenheim GmbH
  • Type of provider: öffentlich
External comparative quality assurance
Further information
Bezeichnung
Teilnahme externe Qualitätssicherung yes
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
Quantity performed 37
Exception? No exception
Quantity performed 2
Exception? No exception
Quantity performed 19
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 19
Quantity forecast year: 14
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: no
Quantity performed reporting year: 2
Quantity forecast year: 0
Examination by state associations? no
Exemption? no
Result of the examination by the federal state authorities? no
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 27
Quantity forecast year: 25
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 48
Quantity forecast year: 44
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 37
Quantity forecast year: 48
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 300
Quantity forecast year: 299
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
No. Explanation
CQ01 Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
CQ05 Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1
CQ27 Guideline on quality assurance measures for inpatient care with bronchoscopic lung volume reduction procedures for severe emphysema (QS Guideline bronchoscopic LVR /QS-RL BLVR)
CQ25 Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: yes
Number Group
233 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
25 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
23 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission

Prozess Umgang mit der Medikation in der eFA (RoMed-06977)

10.06.2022

Leitlinie zur Arzneimitteltherapiesicherheit / AMTS (RO-07773)

06.06.2023

  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Zubereitung durch pharmazeutisches Personal
  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Fallbesprechungen
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • SOP Arzneimitteltherapiesicherheit
  • Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
  • Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Lehrkrankenhaus der Ludwig-Maximilians-Universität München und Medizinische Privatuniversität Paracelsus, Salzburg

Explanation

IT Projekte mit der Hochschule Rosenheim, Praktika

Explanation

Explanation

Fachbereich Betriebswirtschaft, Gesundheitsmanagement, Hochschule Rosenheim

Explanation

Explanation

Explanation

Training in other healing professions
Comment

Comment

Comment

Comment

Comment

Klinisch-praktische Ausbildung erfolgt im RoMed-Klinikum Rosenheim

Comment

Kooperation für den primärqualifizierenden Studiengang der Technischen Hochschule Rosenheim

Comment

Kooperation für die fachpraktischen Ausbildungsanteile des Studiengangs Physiotherapie der Technischen Hochschule Rosenheim

Comment

Volker Schmidt

Patientenfürsprecher

Ellmaierstraße 23
83022 Rosenheim

Phone: 08031 -365-7122
Mail: ed.dem-or@rehcerpsreufnetneitap

Vjera Eberle

Ass. Klinikleitung

Ellmaierstraße 23
83022 Rosenheim

Phone: 08031 -365-3828
Mail: ed.dem-or@or.kcabdeef

Susanne Bleiziffer

Ass. Klinikleitung

Ellmaierstraße 23
83022 Rosenheim

Phone: 08031 -365-3828
Mail: ed.dem-or@or.kcabdeef

Sandra Mayer-Huber

Leitung zentrales Qualitätsmanagement

Ellmaierstraße 23
83022 Rosenheim

Phone: 08031 -365-6615
Mail: ed.dem-or@rebuh-reyam.ardnas

Stephanie Lutz

Qualitätsmanagementbeauftragte

Ellmaierstraße 23
83022 Rosenheim

Phone: 08031 -365-6076
Mail: ed.dem-or@ztul.einahpets

Dr. med. Birgitt Mergen

Ärztliche Leiterin Abteilung für Krankenhaushygiene und Antibiotic Stewardship

Ellmaierstraße 23
83022 Rosenheim

Phone: 08031 -365-3751
Mail: ed.dem-or@eneigyh

Stephanie Hugues-Schulze

Leitung Apotheke

Ellmaierstraße 23
83022 Rosenheim

Phone: 08031 -365-3730
Mail: ed.dem-or@ezluhcs-seuguh.einahpets

Astrid Schenck

Sozialdienst

Ellmaierstraße 23
83022 Rosenheim

Phone: 08031 -365-3757
Mail: ed.dem-or@kcnehcS.dirtsA

Ellmaierstraße 23
83022 Rosenheim

Phone: 08031-36502
Fax: +498031-365-4820
Mail: ed.dem-or@or.ofni

Hans Albert

Pflegedienstleitung

Ellmaierstraße 23
83022 Rosenheim

Phone: 08031 -365-3801
Mail: ed.dem-or@trebla.snah

Dr. Martina Bielawski

Kaufmännische Leiterin

Ellmaierstraße 23
83022 Rosenheim

Phone: 08031 -365-7002
Mail: ed.dem-or@or.gnutielkinilk

PD Dr. med. Andreas Bauer

Ärztlicher Direktor

Ellmaierstraße 23
83022 Rosenheim

Phone: 08031 -365-3501
Mail: ed.dem-or@or.eisehtseana

PD Dr. med. Andreas Bauer

Ärztlicher Direktor

Ellmaierstraße 23
83022 Rosenheim

Phone: 08031 -365-3501
Mail: ed.dem-or@or.eisehtseana

IK: 260910637

More IK: 260910637

Location number: 772849000

Old location number: 772849000

Kooperatives Brustzentrum Südostbayern

Kooperatives Brustzentrum Südostbayern

Certified until: 04.2026

Gynäkologisches Krebszentrum Rosenheim

Gynäkologisches Krebszentrum Rosenheim

Certified until: 04.2026

Viszeralonkologisches Zentrum für Darm, Bauchspeicheldrüse und Magen

Viszeralonkologisches Zentrum für Darm, Bauchspeicheldrüse und Magen

Certified until: 04.2026

Onkologisches Zentrum RoMed Klinikum Rosenheim

Onkologisches Zentrum RoMed Klinikum Rosenheim

Certified until: 04.2026

Nierenkrebszentrum

Nierenkrebszentrum

Certified until: 04.2026